Dyspareunia

74 registered clinical trials studyying Dyspareunia — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia NCT07504991	Institut Investigacio Sanitaria Pere Virgili	N/A
Not Yet Recruiting	Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial NCT07260825	TriHealth Inc.	Phase 2 / Phase 3
Recruiting	Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Wo NCT06710002	Instituto Médico Tecnológico SL	N/A
Recruiting	Biomodulation and Rehabilitation Interventions to TarGet Pelvic Health NCT06660212	University of Ottawa	N/A
Recruiting	VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia NCT06840314	Medstar Health Research Institute	N/A
Recruiting	Use of TDCS Stimulation in Neurological and Gynaecological Conditions NCT06891690	Poznan University of Physical Education	N/A
Completed	Manual Therapy in Improving Quality of Life in Women With Dyspareunia NCT07495085	University of Trás-os-Montes and Alto Douro	N/A
Not Yet Recruiting	Effects of Photobiomodulation on Pain and Sexual Function in Women With Dyspareunia: Randomized Clinical Trial NCT06460415	Federal University of Health Science of Porto Alegre	N/A
Active Not Recruiting	Prospective on Market Patient-reported Outcomes for Milli NCT06397885	Materna Medical	—
Recruiting	Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy NCT06059586	Indiana University	N/A
Recruiting	Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assesse NCT06962345	Mucosa Innovations, S.L.	N/A
Recruiting	Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach NCT05761275	Jean Dubuisson	N/A
Completed	Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag Laser NCT06000202	Istanbul University - Cerrahpasa	N/A
Terminated	Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis NCT05540353	Medstar Health Research Institute	N/A
Completed	Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action NCT05644444	Reckitt Benckiser Healthcare (UK) Limited	N/A
Unknown	Symptoms and Quality of Life of Patients With Suspected Endometriosis NCT05624567	Medical University of Vienna	—
Active Not Recruiting	Genital Laser Treatment in Postmenopausal Patients NCT05631665	Kanuni Sultan Suleyman Training and Research Hospital	N/A
Completed	Effects of Myofascial Release With and Without Thiele Massage NCT05834088	Riphah International University	N/A
Completed	Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment NCT05617820	Teva Pharmaceuticals USA	Phase 3
Withdrawn	Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia NCT05129332	Columbia University	N/A
Completed	Evaluation of Yoga and Conventional Physical Exercise for Pain and Quality of Life in Women With Endometriosis NCT07424859	Beneficência Portuguesa de São Paulo	N/A
Unknown	To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser NCT05156502	Dr. Filippo Murina	N/A
Unknown	The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device NCT05445115	JSP Innovations	N/A
Unknown	Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health NCT02484196	University of Cagliari	—
Unknown	Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort NCT04885556	Atlantic Health System	N/A
Recruiting	Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum. NCT05417334	Hospital Clinic of Barcelona	N/A
Completed	A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants. NCT04908124	Reckitt Benckiser Healthcare (UK) Limited	Phase 3
Completed	What is the Nature of Pelvic Floor Muscle Involvement in Dyspareunia? NCT04234555	University of Ottawa	—
Completed	Postpartum Sexual Function in Pregnant Women With COVID-19 NCT04389489	Kanuni Sultan Suleyman Training and Research Hospital	—
Completed	Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatmen NCT04868812	IRCCS San Raffaele	N/A
Completed	Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of t NCT04659668	Mesoestetic Pharma Group S.L.	N/A
Unknown	Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy NCT03782480	Center for Vulvovaginal Disorders	Phase 3
Unknown	Vaginal Laser Therapy in Breast Cancer Survivors NCT03738605	National and Kapodistrian University of Athens	N/A
Unknown	Laser Therapy Following Radiotherapy for Gynecological Cancer NCT03714581	National and Kapodistrian University of Athens	N/A
Completed	Laser Therapy for Treatment of Urogenital Symptoms in Women NCT03681678	Corewell Health East	—
Withdrawn	Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Can NCT03666819	Mayo Clinic	Phase 2
Terminated	Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment NCT03682601	GTO Pharmaceutical, LLC	Phase 2
Completed	Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareun NCT03568604	San Diego Sexual Medicine	Phase 4
Completed	Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivo NCT03372720	Ohio State University Comprehensive Cancer Center	N/A
Unknown	Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors NCT03257670	University of Cincinnati	N/A
Completed	Acupuncture for Vulvodynia: A Pre-pilot Study NCT02704234	University of Illinois at Chicago	N/A
Completed	The Influence of Prepartum Perineal Training With the Epi-No Device on Pelvic Floor Function. NCT05282160	Universidade Estadual de Londrina	N/A
Completed	Fractional CO2 Laser Therapy for Survivors of Breast Malignancies NCT03307044	Ohio State University Comprehensive Cancer Center	N/A
Completed	Effects of Epi-no Device on Pelvic Floor Dysfunctions NCT04955418	Universidade Estadual de Londrina	N/A
Unknown	CBT Group Treatment for Women With Dyspareunia NCT03427255	Örebro University, Sweden	N/A
Completed	Dyspareunia and Central Sensitization NCT03216330	BC Women's Hospital & Health Centre	—
Completed	Treating Postmenopausal Dyspareunia Where it Hurts NCT03240081	Oregon Health and Science University	Phase 4
Completed	Electrolysis Technique vs Manual Therapy in Pelvic Pain NCT03163160	Quirón Madrid University Hospital	N/A
Completed	Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule NCT02739880	Centre Hospitalier Universitaire de Nīmes	N/A
Completed	Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women NCT03116022	University of Sao Paulo	Phase 1
Completed	A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dy NCT03199534	EvergreenHealth	Phase 4
Completed	Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause NCT03178825	Sciton	N/A
Terminated	GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors NCT03185169	Alta Bates Summit Medical Center	EARLY_Phase 1
Completed	Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study NCT03935698	Université de Sherbrooke	N/A
Completed	Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain NCT02795026	Cork University Hospital	N/A
Completed	A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy NCT02670785	Warner Chilcott	Phase 2
Completed	Evaluation of the Neural Therapy Effect on Long Term Postoperative Discomforts in Patients Who Undergo Bilater NCT03761862	Kanuni Sultan Suleyman Training and Research Hospital	—
Completed	Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA NCT02784613	Sue Goldstein	Phase 4
Completed	Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair NCT03184077	Virginia Commonwealth University	N/A
Completed	Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women NCT02253173	TherapeuticsMD	Phase 3
Unknown	Continuous Versus Cyclic Oral Contraceptives for Endometriosis NCT02237131	University of Athens	Phase 4
Completed	Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia NCT01935063	Université de Montréal	N/A
Unknown	Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain NCT02022722	University of Cincinnati	Phase 4
Completed	TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vagin NCT02449902	TherapeuticsMD	Phase 2
Completed	Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therap NCT01697345	Creighton University	EARLY_Phase 1
Completed	Outcomes of Delivery in Patients With Dyspareunia NCT01753258	Hadassah Medical Organization	—
Completed	Physiotherapy Intervention in Climacteric Women With Dyspareunia NCT02804048	Hospital de Clinicas de Porto Alegre	N/A
Completed	Acupuncture for the Treatment of Vulvodynia NCT02197429	Schlaeger, Judith M., CNM, LAc, PhD	N/A
Completed	Therapy to Prevent Sexual Pain in Breast Cancer Survivors NCT01539317	OHSU Knight Cancer Institute	Phase 3
Withdrawn	Randomized Trial of Interrupted Versus Continuous Vaginal Closure of Anterior Repair With Mesh NCT00676000	Brigham and Women's Hospital	N/A
Suspended	Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. NCT01122342	University of Vermont	Phase 1 / Phase 2
Completed	Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in NCT00318500	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 2
Completed	Sexual Dysfunction and Dental Care NCT00281372	Sheba Medical Center	—
Unknown	Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist NCT00458458	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 3